A. Zinsmeister

发表

Age at onset of inflammatory bowel disease and the risk of surgery for non‐neoplastic bowel disease

A. Zinsmeister, W. Harmsen, W. Sandborn, 2007, Alimentary pharmacology & therapeutics.

Impact of functional gastrointestinal disorders on health‐related quality of life: a population‐based case–control study

A. Zinsmeister, G. Locke, N. Talley, 2004, Alimentary pharmacology & therapeutics.

Predictors of the placebo response in functional dyspepsia

A. Zinsmeister, B. Lahr, G. Locke, 2006, Alimentary pharmacology & therapeutics.

Influence of alcohol consumption on IBS and dyspepsia

A. Zinsmeister, C. Schleck, G. Locke, 2006, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Double‐blind, randomized, placebo‐controlled study to evaluate the effects of tegaserod on gastric motor, sensory and myoelectric function in healthy volunteers

A. Zinsmeister, M. Camilleri, D. Burton, 2006, Alimentary pharmacology & therapeutics.

The effect of new diagnostic criteria for irritable bowel syndrome on community prevalence estimates

A. Zinsmeister, G. Locke, N. Talley, 2000, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Non‐enteric infections, antibiotic use, and risk of development of functional gastrointestinal disorders

A. Zinsmeister, C. Schleck, G. Locke, 2015, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Clinical predictors of small intestinal bacterial overgrowth by duodenal aspirate culture

A. Zinsmeister, A. Malhotra, W. Harmsen, 2011, Alimentary pharmacology & therapeutics.

The role of ultrasonography and automatic‐needle biopsy in outpatient percutaneous liver biopsy

J Rakela, A R Zinsmeister, E M James, 1996, Hepatology.

Bismuth carbomer foam enemas for active chronic pouchitis: a randomized, double‐blind, placebo‐controlled trial

W. Sandborn, W. Tremaine, P. Metzger, 1997, Alimentary pharmacology & therapeutics.

Prevalence and risk factors for dysphagia: a USA community study

A. Zinsmeister, C. Schleck, G. Locke, 2015, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Reproducibility of high‐definition (3D) manometry and its agreement with high‐resolution (2D) manometry in women with fecal incontinence

A. Zinsmeister, A. Bharucha, S. Chakraborty, 2017, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Duodenal mastocytosis, eosinophilia and intraepithelial lymphocytosis as possible disease markers in the irritable bowel syndrome and functional dyspepsia

A. Zinsmeister, W. Harmsen, N. Talley, 2009, Alimentary pharmacology & therapeutics.

Multiple functional gastrointestinal disorders linked to gastroesophageal reflux and somatization: A population‐based study

C. Schleck, N. Talley, R. Choung, 2017, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Cyclic vomiting syndrome and functional vomiting in adults: association with cannabinoid use in males

A. Zinsmeister, C. Schleck, G. Locke, 2012, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

A new questionnaire for constipation and faecal incontinence

A. Zinsmeister, G. Locke, A. Bharucha, 2004, Alimentary pharmacology & therapeutics.

The incidence rate and characteristics of clinically diagnosed defecatory disorders in the community

G. Locke, R. Choung, J. Eaton, 2016, Neurogastroenterology and Motility.

Validating endpoints for therapeutic trials in fecal incontinence

A. E. Bharucha, A. R. Zinsmeister, J. Noelting, 2016, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Effect of female sex hormone supplementation and withdrawal on gastrointestinal and colonic transit in postmenopausal women

A. Zinsmeister, M. Camilleri, D. Burton, 2006, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Effect of colesevelam on faecal bile acids and bowel functions in diarrhoea‐predominant irritable bowel syndrome

A. Zinsmeister, M. Camilleri, L. Donato, 2015, Alimentary pharmacology & therapeutics.

Overlap of dyspepsia and gastroesophageal reflux in the general population: one disease or distinct entities?

A. Zinsmeister, C. Schleck, G. Locke, 2012, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Clinical predictors of small intestinal bacterial overgrowth by duodenal aspirate culture: authors’ reply

R. Choung, N. J. Talley, A. Zinsmeister, 2011 .

The changing incidence of oesophageal and gastric adenocarcinoma by anatomic sub‐site

A. Zinsmeister, W. Harmsen, S. Crane, 2006, Alimentary pharmacology & therapeutics.

Measurement of abdominal symptoms by validated questionnaire: a 3‐month recall timeframe as recommended by Rome III is not superior to a 1‐year recall timeframe

A. Zinsmeister, A. Malhotra, T. Beebe, 2010, Alimentary pharmacology & therapeutics.

Relationship between upper gastrointestinal symptoms and changes in body weight in a population‐based cohort

A. Zinsmeister, C. Schleck, G. Locke, 2006, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Asimadoline, a kappa‐opioid agonist, and satiation in functional dyspepsia

A. Zinsmeister, M. Camilleri, R. Choung, 2008, Alimentary pharmacology & therapeutics.

Risk factors for chronic constipation and a possible role of analgesics

C. Schleck, G. Locke, N. Talley, 2007, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Is irritable bowel syndrome more likely to be persistent in those with relatives who suffer from gastrointestinal symptoms? A population‐based study at three time points

L. Melton, A. Zinsmeister, G. Locke, 2003, Alimentary pharmacology & therapeutics.

Epidemiology of slow and fast colonic transit using a scale of stool form in a community

A. Zinsmeister, C. Schleck, G. Locke, 2007, Alimentary pharmacology & therapeutics.

Relationship between body mass index, diet, exercise and gastro‐oesophageal reflux symptoms in a community

G. Locke, N. Talley, A. Cameron, 2004, Alimentary pharmacology & therapeutics.

Overdiagnosis of gastro‐esophageal reflux disease and underdiagnosis of functional dyspepsia in a USA community

A. Zinsmeister, C. Schleck, G. Locke, 2014, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Opioid analgesic use among patients presenting with acute abdominal pain and factors associated with surgical diagnoses

A. Zinsmeister, M. Camilleri, D. Khemani, 2017, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

The effects of clonidine on symptoms and anorectal sensorimotor function in women with faecal incontinence

A. Zinsmeister, A. Bharucha, B. Seide, 2010, Alimentary pharmacology & therapeutics.

Risk factors for non‐cardiac chest pain in the community

G. Locke, J. Wise, N. J. Talley, 2005, Alimentary pharmacology & therapeutics.

The effect of short‐term, low‐dose tricyclic and tetracyclic antidepressant treatment on satiation, postnutrient load gastrointestinal symptoms and gastric emptying: a double‐blind, randomized, placebo‐controlled trial

R. Choung, F. Cremonini, N. J. Talley, 2008, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Irritable bowel syndrome and the perinatal period: lower birth weight increases the risk

C. Schleck, G. Locke, N. J. Talley, 2016, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Biliary events and an increased risk of new onset irritable bowel syndrome: a population‐based cohort study

C D Schleck, A R Zinsmeister, A. Zinsmeister, 2008, Alimentary pharmacology & therapeutics.

Design of treatment trials for functional gastrointestinal disorders

P. Whorwell, A. Zinsmeister, N. Talley, 1999, Gut.

Discriminant value of psychological distress, symptom profiles, and segmental colonic dysfunction in outpatients with severe idiopathic constipation.

A. Zinsmeister, N. Talley, N. J. Talley, 1994, Gut.

The effects of ageing on the onset and disappearance of unexplained abdominal pain: a population‐based study

A. Zinsmeister, C. Schleck, G. Locke, 2014, Alimentary pharmacology & therapeutics.

Semi‐automated vectorial analysis of anorectal motion by magnetic resonance defecography in healthy subjects and fecal incontinence

A. Manduca, A. Zinsmeister, S. Riederer, 2012, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.